Published in Proc Natl Acad Sci U S A on September 30, 2008
Virology, immunology and pathology of human rabies during treatment. Pediatr Infect Dis J (2015) 2.06
The cell biology of rabies virus: using stealth to reach the brain. Nat Rev Microbiol (2010) 1.86
CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity. J Exp Med (2011) 1.82
Glymphatic distribution of CSF-derived apoE into brain is isoform specific and suppressed during sleep deprivation. Mol Neurodegener (2016) 1.38
Role of chemokines in the enhancement of BBB permeability and inflammatory infiltration after rabies virus infection. Virus Res (2009) 1.34
The production of antibody by invading B cells is required for the clearance of rabies virus from the central nervous system. PLoS Negl Trop Dis (2009) 1.34
Links between progressive HIV-1 infection of humanized mice and viral neuropathogenesis. Am J Pathol (2010) 1.09
The roles of chemokines in rabies virus infection: overexpression may not always be beneficial. J Virol (2009) 1.02
Human brain endothelial cells are responsive to adenosine receptor activation. Purinergic Signal (2011) 0.90
Ambivalent role of the innate immune response in rabies virus pathogenesis. J Virol (2011) 0.87
Rabies virus glycoprotein is an important determinant for the induction of innate immune responses and the pathogenic mechanisms. Vet Microbiol (2012) 0.85
Fibronectin inhibits chronic pain development after spinal cord injury. J Neurotrauma (2012) 0.83
The critical role of antigen-presentation-induced cytokine crosstalk in the central nervous system in multiple sclerosis and experimental autoimmune encephalomyelitis. J Interferon Cytokine Res (2011) 0.80
Intrathecal humoral immunity to encephalitic RNA viruses. Viruses (2013) 0.80
Cannabinoid receptor type-2 stimulation, blockade, and deletion alter the vascular inflammatory responses to traumatic brain injury. J Neuroinflammation (2014) 0.80
Blood-brain barrier transport studies, aggregation, and molecular dynamics simulation of multiwalled carbon nanotube functionalized with fluorescein isothiocyanate. Int J Nanomedicine (2015) 0.79
Expression of interferon gamma by a recombinant rabies virus strongly attenuates the pathogenicity of the virus via induction of type I interferon. J Virol (2014) 0.78
Role of the blood-brain barrier in rabies virus infection and protection. Protein Cell (2013) 0.76
Aurintricarboxylic acid ameliorates experimental autoimmune encephalomyelitis by blocking chemokine-mediated pathogenic cell migration and infiltration. J Immunol (2012) 0.76
Subcortical brain atrophy in Gulf War Illness. Exp Brain Res (2017) 0.76
Novel Approaches to the Prevention and Treatment of Rabies. Int J Virol Stud Res (2015) 0.75
T-bet Is Required for the Rapid Clearance of Attenuated Rabies Virus from Central Nervous System Tissue. J Immunol (2015) 0.75
Type 1 Immune Mechanisms Driven by the Response to Infection with Attenuated Rabies Virus Result in Changes in the Immune Bias of the Tumor Microenvironment and Necrosis of Mouse GL261 Brain Tumors. J Immunol (2017) 0.75
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med (2005) 28.73
Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol (2007) 6.67
Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest (1996) 3.64
Evans blue dye as a marker of albumin clearance in cultured endothelial monolayer and isolated lung. J Appl Physiol (1985) (1992) 2.50
Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study. Brain (2003) 2.37
Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci U S A (1998) 2.21
Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system. J Virol (1998) 2.15
Evans blue fluorescence: quantitative and morphological evaluation of vascular permeability in animal tissues. J Neurosci Methods (1983) 1.98
Regional differences in blood-brain barrier permeability changes and inflammation in the apathogenic clearance of virus from the central nervous system. J Immunol (2006) 1.94
Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis. FASEB J (2000) 1.75
The role of uric acid in protection against peroxynitrite-mediated pathology. Med Hypotheses (2001) 1.74
Reaction of uric acid with peroxynitrite and implications for the mechanism of neuroprotection by uric acid. Arch Biochem Biophys (2000) 1.62
Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc Natl Acad Sci U S A (1997) 1.42
Blood-brain and blood-spinal cord barrier permeability during the course of experimental allergic encephalomyelitis in the rat. Brain Res (1984) 1.40
A peroxynitrite-dependent pathway is responsible for blood-brain barrier permeability changes during a central nervous system inflammatory response: TNF-alpha is neither necessary nor sufficient. J Immunol (2007) 1.29
Multiple sclerosis: gadolinium enhancement in MR imaging. Radiology (1986) 1.29
Quantitative multi-gene transcriptional profiling using real-time PCR with a master template. Exp Mol Pathol (2005) 1.27
Inducible nitric oxide synthase activation by interleukin-17. Cytokine Growth Factor Rev (2004) 1.16
The central nervous system inflammatory response to neurotropic virus infection is peroxynitrite dependent. J Immunol (2001) 1.14
Loss of blood-brain barrier integrity in the spinal cord is common to experimental allergic encephalomyelitis in knockout mouse models. Proc Natl Acad Sci U S A (2007) 1.05
Uricase protein sequences: conserved during vertebrate evolution but absent in humans. FASEB J (1988) 1.04
Evidence for the production of peroxynitrite in inflammatory CNS demyelination. J Neuroimmunol (1997) 1.02
SIN-1-induced cytotoxicity in mixed cortical cell culture: peroxynitrite-dependent and -independent induction of excitotoxic cell death. J Neurochem (2001) 0.96
Modulation of blood-brain barrier dysfunction and neurological deficits during acute experimental allergic encephalomyelitis by the N-methyl-D-aspartate receptor antagonist memantine. J Pharmacol Exp Ther (2002) 0.95
Protection of myelin basic protein immunized mice from free-radical mediated inflammatory cell invasion of the central nervous system by the natural peroxynitrite scavenger uric acid. Neurosci Lett (2000) 0.92
ICAM-1 upregulation in the spinal cords of PLSJL mice with experimental allergic encephalomyelitis is dependent upon TNF-alpha production triggered by the loss of blood-brain barrier integrity. J Neuroimmunol (2004) 0.91
Peroxynitrite-induced oligodendrocyte toxicity is not dependent on poly(ADP-ribose) polymerase activation. Glia (2003) 0.86
Regional differences in blood-brain barrier permeability changes and inflammation in the apathogenic clearance of virus from the central nervous system. J Immunol (2006) 1.94
Rabies transmission from organ transplants in the USA. Lancet (2004) 1.92
The treatment of multiple sclerosis with inosine. J Altern Complement Med (2009) 1.48
Failure to open the blood-brain barrier and deliver immune effectors to central nervous system tissues leads to the lethal outcome of silver-haired bat rabies virus infection. J Virol (2006) 1.42
Identification of viral genomic elements responsible for rabies virus neuroinvasiveness. Proc Natl Acad Sci U S A (2004) 1.41
Tobacco as a production platform for biofuel: overexpression of Arabidopsis DGAT and LEC2 genes increases accumulation and shifts the composition of lipids in green biomass. Plant Biotechnol J (2009) 1.34
Effective preexposure and postexposure prophylaxis of rabies with a highly attenuated recombinant rabies virus. Proc Natl Acad Sci U S A (2009) 1.34
The production of antibody by invading B cells is required for the clearance of rabies virus from the central nervous system. PLoS Negl Trop Dis (2009) 1.34
A peroxynitrite-dependent pathway is responsible for blood-brain barrier permeability changes during a central nervous system inflammatory response: TNF-alpha is neither necessary nor sufficient. J Immunol (2007) 1.29
Uric acid protects against secondary damage after spinal cord injury. Proc Natl Acad Sci U S A (2005) 1.24
Therapeutic intervention in experimental allergic encephalomyelitis by administration of uric acid precursors. Proc Natl Acad Sci U S A (2002) 1.22
Lethal silver-haired bat rabies virus infection can be prevented by opening the blood-brain barrier. J Virol (2007) 1.18
A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies. J Gen Virol (2005) 1.17
Function and glycosylation of plant-derived antiviral monoclonal antibody. Proc Natl Acad Sci U S A (2003) 1.16
Effects of treatments on inflammatory and apoptotic markers in the CNS of mice with globoid cell leukodystrophy. Brain Res (2009) 1.12
Immune evasion by rabies viruses through the maintenance of blood-brain barrier integrity. J Neurovirol (2008) 1.10
Inhibition of tumor growth by plant-derived mAb. Proc Natl Acad Sci U S A (2005) 1.08
Glioma grade is associated with the accumulation and activity of cells bearing M2 monocyte markers. Clin Cancer Res (2013) 1.07
Development of a cocktail of recombinant-expressed human rabies virus-neutralizing monoclonal antibodies for postexposure prophylaxis of rabies. J Infect Dis (2003) 1.07
Loss of blood-brain barrier integrity in the spinal cord is common to experimental allergic encephalomyelitis in knockout mouse models. Proc Natl Acad Sci U S A (2007) 1.05
Comparison of uric acid and ascorbic acid in protection against EAE. Free Radic Biol Med (2002) 1.05
CXCR3-dependent plasma blast migration to the central nervous system during viral encephalomyelitis. J Virol (2011) 1.05
The therapeutic effects of PJ34 [N-(6-oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide.HCl], a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are associated with immunomodulation. J Pharmacol Exp Ther (2004) 0.99
IFN-γ signaling to astrocytes protects from autoimmune mediated neurological disability. PLoS One (2012) 0.97
Poly(ADP-ribose) polymerase activity contributes to peroxynitrite-induced spinal cord neuronal cell death in vitro. J Neurotrauma (2004) 0.96
Rabies virus nucleoprotein as a carrier for foreign antigens. Proc Natl Acad Sci U S A (2004) 0.94
Shifting hierarchies of interleukin-10-producing T cell populations in the central nervous system during acute and persistent viral encephalomyelitis. J Virol (2011) 0.93
Plant-derived anti-Lewis Y mAb exhibits biological activities for efficient immunotherapy against human cancer cells. Proc Natl Acad Sci U S A (2006) 0.92
Plant biopharming of monoclonal antibodies. Virus Res (2005) 0.92
Elimination of alkaloids from plant-derived human monoclonal antibody. J Immunol Methods (2004) 0.91
ICAM-1 upregulation in the spinal cords of PLSJL mice with experimental allergic encephalomyelitis is dependent upon TNF-alpha production triggered by the loss of blood-brain barrier integrity. J Neuroimmunol (2004) 0.91
Circadian variation in oxidative stress markers in healthy and type II diabetic men. Chronobiol Int (2002) 0.91
Severe acute respiratory syndrome (SARS) S protein production in plants: development of recombinant vaccine. Proc Natl Acad Sci U S A (2005) 0.91
Smallpox subunit vaccine produced in Planta confers protection in mice. Proc Natl Acad Sci U S A (2007) 0.90
Intracellular reprogramming of expression, glycosylation, and function of a plant-derived antiviral therapeutic monoclonal antibody. PLoS One (2013) 0.89
Plant based HIV-1 vaccine candidate: Tat protein produced in spinach. Vaccine (2005) 0.89
Plant-derived EpCAM antigen induces protective anti-cancer response. Cancer Immunol Immunother (2007) 0.88
Controlled glycosylation of therapeutic antibodies in plants. Arch Biochem Biophys (2004) 0.87
Peroxynitrite-induced oligodendrocyte toxicity is not dependent on poly(ADP-ribose) polymerase activation. Glia (2003) 0.86
Therapeutic immune clearance of rabies virus from the CNS. Future Virol (2011) 0.86
The role of toll-like receptors in the induction of immune responses during rabies virus infection. Adv Virus Res (2011) 0.85
Rabies virus clearance from the central nervous system. Adv Virus Res (2011) 0.85
Temporal changes in innate immune signals in a rat model of alcohol withdrawal in emotional and cardiorespiratory homeostatic nuclei. J Neuroinflammation (2012) 0.84
Differential expression of growth factors at the cellular level in virus-infected brain. Proc Natl Acad Sci U S A (2003) 0.83
Early blood-brain barrier permeability in cerebella of PLSJL mice immunized with myelin basic protein. J Neuroimmunol (2008) 0.83
Gamma interferon signaling in oligodendrocytes is critical for protection from neurotropic coronavirus infection. J Virol (2009) 0.83
Role of CD25(+) CD4(+) T cells in acute and persistent coronavirus infection of the central nervous system. Virology (2013) 0.81
Immunization with a plant-produced colorectal cancer antigen. Cancer Immunol Immunother (2003) 0.80
Expression of a human anti-rabies virus monoclonal antibody in tobacco cell culture. Biochem Biophys Res Commun (2006) 0.79
Combination nonviral interleukin 2 gene therapy and external-beam radiation therapy for head and neck cancer. Arch Otolaryngol Head Neck Surg (2003) 0.79
Role of uric acid in Alzheimer's disease. J Alzheimers Dis (2010) 0.78
Glioblastoma exosomes and IGF-1R/AS-ODN are immunogenic stimuli in a translational research immunotherapy paradigm. Cancer Immunol Immunother (2014) 0.78
Aleuria Aurantia Lectin (AAL)-reactive immunoglobulin G rapidly appears in sera of animals following antigen exposure. PLoS One (2012) 0.78
Inhibition of hypochlorous acid-induced cellular toxicity by nitrite. Proc Natl Acad Sci U S A (2002) 0.77
Enhancement of glioma-specific immunity in mice by "NOBEL", an insulin-like growth factor 1 receptor antisense oligodeoxynucleotide. Cancer Immunol Immunother (2015) 0.77
Serum and cerebrospinal fluid uric acid levels in multiple sclerosis patients. Clin Neurol Neurosurg (2008) 0.77
Plant-produced hepatitis B core protein chimera carrying anthrax protective antigen domain-4. Hybridoma (Larchmt) (2008) 0.76
Immunogenic properties of plant-derived recombinant smallpox vaccine candidate pB5. Vaccine (2008) 0.76
Reactive oxygen/nitrogen species at the fulcrum of life-death decisions: a commentary on "peroxynitrite transforms nerve growth factor into an apoptotic factor for motor neurons". Free Radic Biol Med (2006) 0.75
Screening of organ and tissue donors for rabies. Lancet (2005) 0.75
Pathogenesis of Alfalfa mosaic virus in Soybean (Glycine max) and Expression of Chimeric Rabies Peptide in Virus-Infected Soybean Plants-A Reexamination. Phytopathology (2002) 0.75